Sign in
Download Opera News App

News Politics




Africa politics

Glamour Of Hope After Researchers Commence The Trials of HIV Injectable Drugs in East Africa

Researchers from Uganda have Kick-started the trial of the injectable HIV drugs which include cabotegravir and rilpivirine. According to the researchers, the drug will help end fatique, fight stigma, improve adherence and ensure the patients get the right dosage. Previously, the drugs were administered in form of tablets but recently the WHO licensed their use to be Injectable.[Photo Courtesy]

Uganda, Kenya and South Africa are the only countries in Africa that have been licenced and approved to perform trials on the drugs. However, Kenya and South Africa have not done their trials and are waiting further direction from the WHO. Therefore, Kenya and South Africa might have to wait until early next year for them to perform the trial.

Uganda and Kenya will both have three trial site while South Africa will have only two. The total number of participants required is 512; 202 from Uganda, 160 from Kenya and 150 from South Africa. Dr. Ivan Mambule who is the lead project researcher at the Joint Clinical Research centre in Uganda has concluded that the participants will need one injection after every two month

Content created and supplied by: TheeWriter (via Opera News )

Africa HIV Kenya South Africa Uganda


Load app to read more comments